SOUTH SAN FRANCISCO, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing novel T cell engagers, today announced that management will participate in two upcoming investor conferences in September. Citi’s 18th Annual BioPharma Conference being held in Boston on September 6-7, 2023.…Read More
Harpoon Therapeutics to Participate in Two Upcoming Investor Conferences in September
